Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- New Therapeutic GL for Arteriosclerotic Diseases Published
August 19, 2002
- ACNielsen, So-net M3 to Start Market Survey Service via MR-kun
August 19, 2002
- Shionogi to Collaborate with Oncotherapy Science for Genome-based Drug Discovery
August 19, 2002
- Chronic Heart Failure as Additional Indication Approved for Daiichi's Carvedilol
August 19, 2002
- Nippon Kayaku Developing DDS for Anticancer Drugs
August 19, 2002
- Toho Prepared for End Deals if Accord Not to Be Reached on Prices
August 19, 2002
- PRESS SEMINAR
August 19, 2002
- Ca Antagonists to Coexist with AII Antagonists
August 19, 2002
- Terumo's Hepaflush Prefilled Syringes Selling Well
August 19, 2002
- BUSINESS NEWS IN BRIEF
August 19, 2002
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
August 19, 2002
- AMO Japan Sees Split from Allergan as a Major Advantage: President Akedo
August 19, 2002
- OTC NEWS IN BRIEF
August 19, 2002
- Taisho, Toyama Agree to Form Capital, Business Alliance
August 19, 2002
- NEW PRODUCTS
August 19, 2002
- Olympus to Raise Sales to \870 Bil. in 5 Years
August 19, 2002
- MEETING
August 19, 2002
- CORPORATE ROUNDUP NEWS IN BRIEF
August 19, 2002
- MEDICAL DEVICE NEWS IN BRIEF
August 19, 2002
- To Further Concentrate on Ethical Drug Business: Takeda President
August 19, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…